US20110059919A1 - Antiviral composition comprising a sulfated polysaccharide - Google Patents

Antiviral composition comprising a sulfated polysaccharide Download PDF

Info

Publication number
US20110059919A1
US20110059919A1 US12/673,145 US67314508A US2011059919A1 US 20110059919 A1 US20110059919 A1 US 20110059919A1 US 67314508 A US67314508 A US 67314508A US 2011059919 A1 US2011059919 A1 US 2011059919A1
Authority
US
United States
Prior art keywords
carrageenan
iota
virus
cells
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/673,145
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marinomed Biotech AG
Original Assignee
Marinomed Biotechnologie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinomed Biotechnologie GmbH filed Critical Marinomed Biotechnologie GmbH
Priority to US12/673,145 priority Critical patent/US20110059919A1/en
Assigned to MARINOMED BIOTECHNOLOGIE GMBH reassignment MARINOMED BIOTECHNOLOGIE GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRASSAUER, ANDREAS, PRIESCHL-GRASSAUER, EVA
Assigned to MARINOMED BIOTECHNOLOGIE GMBH reassignment MARINOMED BIOTECHNOLOGIE GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRASSAUER, ANDREAS, PRIESCHL-GRASSAUER, EVA
Publication of US20110059919A1 publication Critical patent/US20110059919A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
US12/673,145 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide Abandoned US20110059919A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/673,145 US20110059919A1 (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93566807P 2007-08-24 2007-08-24
US12/673,145 US20110059919A1 (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide
PCT/EP2008/006910 WO2009027057A1 (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/006910 A-371-Of-International WO2009027057A1 (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/483,716 Continuation US10342820B2 (en) 2007-08-24 2012-05-30 Antiviral composition comprising a sulfated polysaccharide

Publications (1)

Publication Number Publication Date
US20110059919A1 true US20110059919A1 (en) 2011-03-10

Family

ID=40198591

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/673,145 Abandoned US20110059919A1 (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide
US13/483,716 Active 2028-12-07 US10342820B2 (en) 2007-08-24 2012-05-30 Antiviral composition comprising a sulfated polysaccharide

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/483,716 Active 2028-12-07 US10342820B2 (en) 2007-08-24 2012-05-30 Antiviral composition comprising a sulfated polysaccharide

Country Status (27)

Country Link
US (2) US20110059919A1 (ko)
EP (1) EP2178533B1 (ko)
JP (1) JP5647518B2 (ko)
KR (1) KR101571571B1 (ko)
CN (1) CN101784272B (ko)
AP (1) AP2630A (ko)
BR (1) BRPI0815748B8 (ko)
CA (1) CA2696009C (ko)
CY (1) CY1113949T1 (ko)
DK (1) DK2178533T3 (ko)
EA (1) EA018138B1 (ko)
ES (1) ES2406684T3 (ko)
HK (1) HK1144558A1 (ko)
HR (1) HRP20130402T1 (ko)
IL (1) IL203444A (ko)
MA (1) MA31748B1 (ko)
MX (1) MX2010001986A (ko)
MY (1) MY153900A (ko)
NO (1) NO20100097L (ko)
NZ (1) NZ583511A (ko)
PL (1) PL2178533T3 (ko)
PT (1) PT2178533E (ko)
SI (1) SI2178533T1 (ko)
TN (1) TN2010000086A1 (ko)
UA (1) UA102673C2 (ko)
WO (1) WO2009027057A1 (ko)
ZA (1) ZA201000951B (ko)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013006795A2 (en) 2011-07-07 2013-01-10 Humanitas International Foundation Antiviral compositions and methods of their use
US20160296616A1 (en) * 2013-01-25 2016-10-13 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
US20170196783A1 (en) * 2016-01-13 2017-07-13 Jehangir Gowani Pharyngeal or buccal cavity rinse and process of use thereof
US10220055B2 (en) 2014-01-22 2019-03-05 Nicox S.A. Composition effective against viral conjunctivitis
WO2019046426A1 (en) * 2017-08-30 2019-03-07 Applied Biological Laboratories, Inc. COMPOSITIONS AND METHODS FOR PROTECTING PATHOGENS AND IRRITANTS IN AIR SUSPENSION
US10646438B2 (en) 2010-07-26 2020-05-12 Board Of Regents, The University Of Texas System Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
US10660914B2 (en) * 2015-07-14 2020-05-26 Marinomed Biotech Ag Stuffy nose deblocking composition having antiviral activity
WO2021168173A1 (en) * 2020-02-20 2021-08-26 Synkine Therapeutics, Inc. Methods and compositions for treating viral respiratory infections
WO2021202952A1 (en) * 2020-04-02 2021-10-07 Linhardt Robert John Compositions incorporating sulfated polysaccharides for inhibiting sars-cov-2
CN114264530A (zh) * 2021-12-30 2022-04-01 重庆市畜牧科学院 一种基于Avicel的病毒蚀斑测定方法及其应用
CN114569549A (zh) * 2013-12-03 2022-06-03 格罗力马托斯国际有限公司 离子水性组合物

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884024B2 (en) * 2005-12-27 2018-02-06 Hemant N Joshi Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
BRPI0915119B8 (pt) * 2008-07-01 2021-05-25 Marinomed Biotechnologie Gmbh uso de iota carragenano
EP2381951B1 (en) * 2009-01-28 2015-12-23 Life Science Nutrition AS Compositions and methods of treating viral infections
JP2010248105A (ja) * 2009-04-14 2010-11-04 Bio Plan:Kk ウイルス感染阻害用組成物
US20120189706A1 (en) * 2009-10-06 2012-07-26 Knocean Sciences, Inc. Macrocystis Pyrifera Derived Health and Wellness Products and Methods of Using the Same
NZ599839A (en) 2009-12-22 2014-02-28 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
JP2011168533A (ja) * 2010-02-18 2011-09-01 Kyosei Seiyaku Kk 抗インフルエンザウイルス剤
CN102821770A (zh) * 2010-02-22 2012-12-12 玛丽诺瓦股份有限公司 抗病毒制剂
CN101869110B (zh) * 2010-07-14 2013-03-13 山东圣鹏农药有限公司 一种抗植物病毒病组合物及其应用
FR2969926B1 (fr) 2011-01-04 2017-03-10 Elicityl Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
WO2012126777A1 (en) * 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition of neuraminidase activity
CN102764266A (zh) * 2012-07-30 2012-11-07 吉林省辉南长龙生化药业股份有限公司 褐藻多糖硫酸酯在制备预防和治疗慢性阻塞性肺病药物中的用途
CN102988409A (zh) * 2012-11-26 2013-03-27 合肥博太医药生物技术发展有限公司 硫酸葡聚糖在制备治疗重症肝炎药物中的应用
EP2948158B1 (en) 2013-01-25 2017-09-06 Marinova Pty Ltd Treatment methods
CN103301065A (zh) * 2013-06-27 2013-09-18 辽宁亿灵科创生物医药科技有限公司 一种海藻提取物的鼻喷剂及其制备方法
CN104721221B (zh) * 2015-01-29 2017-08-04 广州暨南生物医药研究开发基地有限公司 琼枝麒麟菜多糖用于制备抗呼吸道病毒药物中的用途
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
CN106309470B (zh) * 2016-08-30 2021-05-18 闫滨 一种羊栖菜多糖的应用
US11045519B2 (en) 2017-01-31 2021-06-29 Unm Rainforest Innovations Arginine-rich polypeptide compositions and methods of using same
JP7261367B2 (ja) * 2018-02-14 2023-04-20 江南化工株式会社 抗ウイルス剤及び抗ウイルス組成物
JP6942350B2 (ja) * 2018-04-26 2021-09-29 江南化工株式会社 抗ウイルス剤及び抗ウイルス用組成物
US20230140869A1 (en) * 2018-07-27 2023-05-11 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
GB2579600B (en) * 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
CN112137953A (zh) * 2019-06-26 2020-12-29 山东百骏生物科技有限公司 一种用于感冒辅助治疗的液体敷料
US11821111B2 (en) 2019-11-15 2023-11-21 Fred Hutchinson Cancer Center Barcoded influenza viruses and deep mutational scanning libraries including the same
JP2023517579A (ja) * 2020-03-09 2023-04-26 オルガンズ ティシューズ リジェネレーション リパレーション レムプレースメント － オーティーアール３ 呼吸器系の病変の治療のための組成物
KR20220159397A (ko) * 2020-03-12 2022-12-02 시드니 데이비드 컬리스-힐 코로나바이러스 감염 및 관련 사이토카인 독성용 치료
WO2021191904A1 (en) * 2020-03-26 2021-09-30 Tree Of Life Pharma Ltd. Methods for preventing and treating viral infection
NL2025335B1 (en) 2020-04-10 2021-10-26 Logick Energetics B V Pharmaceutical composition for treatment of corona virus infection
CN111471088B (zh) * 2020-04-21 2021-02-09 北京中科微盾生物科技有限责任公司 一种抑制sars-cov-2感染的多肽、组合物及其用途
CN111686125A (zh) * 2020-06-18 2020-09-22 大连工业大学 卡拉胶在抗新型冠状病毒中的应用
WO2021253643A1 (zh) * 2020-06-18 2021-12-23 大连工业大学 硫酸化多糖在抗新型冠状病毒中的应用
EP3932411A1 (en) 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Antiviral pharmaceutical composition
EP3932412A1 (en) 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Antiviral pharmaceutical composition
EP3939597A1 (en) 2020-07-16 2022-01-19 Marinomed Biotech AG Antiviral pharmaceutical composition comprising a carrageenan component
CN114053251A (zh) * 2020-07-29 2022-02-18 苏州融析生物科技有限公司 硫酸化多糖吸入制剂及其在防治新冠病毒相关疾病中的应用
CN112220799A (zh) * 2020-11-02 2021-01-15 江苏泰德医药有限公司 一种抑制病毒的产品及用途
WO2022131283A1 (ja) * 2020-12-15 2022-06-23 正一 中村 海藻類及びその抽出物を含有する食品類及び飲料水類
WO2022131282A1 (ja) * 2020-12-15 2022-06-23 正一 中村 海藻類及びその抽出物を含有するせっけん類、消毒剤、殺菌剤及び洗浄剤
EP4079289A1 (en) 2021-04-22 2022-10-26 Dutch Renewable Energy B.V. Anti-viral composition for administration into nose, mouth or throat
EP4079300A1 (en) 2021-04-22 2022-10-26 Dutch Renewable Energy B.V. Anti-viral composition for administration into nose, mouth or throat
GB202109888D0 (en) 2021-07-08 2021-08-25 Pollinner Ltd Nasal spray
EP4130258A1 (en) 2021-08-02 2023-02-08 Evonik Operations GmbH Microorganisms displaying viral decoy receptors
WO2023031929A1 (en) * 2021-08-31 2023-03-09 Polyrizon Ltd. Mucoadhesive polymers for nasal drug delivery
CN114395538A (zh) * 2022-01-19 2022-04-26 和元生物技术（上海）股份有限公司 一种促进重组病毒载体向细胞外分泌的方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
WO1994015624A1 (en) * 1993-01-08 1994-07-21 The Population Council Use of sulphated polysaccharides for preventing sexually transmitted diseases
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
US6391452B1 (en) * 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US6623727B2 (en) * 2000-10-20 2003-09-23 Wella Aktiengesellschaft Solid, form-stable gels for hair treatment
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20050261240A1 (en) * 2002-04-30 2005-11-24 The Population Council, Inc. Carrageenan based antimicrobial compositions
US20080241271A1 (en) * 2006-11-08 2008-10-02 Roman Stephen B Foaming anti-adhesion composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
CH680265A5 (en) * 1990-06-25 1992-07-31 Madeleine Luescher Mattli Dr Polyanionic cpds. for treatment of myxo- and para-myxo-virus diseases - effective against e.g. influenza, measles, mumps and distemper and use e.g. a sulphonated polysaccharide
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
WO1998006396A1 (en) 1996-08-12 1998-02-19 Merck & Co., Inc. Thrombin inhibitors
JPH1180003A (ja) * 1997-09-16 1999-03-23 Yakult Honsha Co Ltd 感染症予防・治療剤
DE19961307A1 (de) 1999-12-18 2001-07-12 Krewel Meuselbach Gmbh Medizinprodukt zur Befeuchtung und Reinigung der Nasenschleimhaut
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤
FR2808687B1 (fr) 2000-04-27 2003-12-05 Goemar Lab Sa Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
EP1296691B1 (en) 2000-06-30 2005-11-02 Polydex Pharmaceuticals Limited Use of cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infections
JP2003081841A (ja) 2001-06-26 2003-03-19 Kikkoman Corp 抗アレルギー体質強化剤
US20060078504A1 (en) * 2003-02-26 2006-04-13 Akira Yamamoto Sustanined-release pharmaceutical composition for lung administration
US20050009782A1 (en) 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
WO2006003521A1 (en) 2004-02-06 2006-01-12 Monash University High dose, short interval use of sulfated polysaccharides for the treatment of infections
US20080184618A1 (en) * 2005-08-03 2008-08-07 Amcol International Virus-Interacting Layered Phyllosilicates and Methods of Use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
WO1994015624A1 (en) * 1993-01-08 1994-07-21 The Population Council Use of sulphated polysaccharides for preventing sexually transmitted diseases
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
US6391452B1 (en) * 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US6623727B2 (en) * 2000-10-20 2003-09-23 Wella Aktiengesellschaft Solid, form-stable gels for hair treatment
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20050261240A1 (en) * 2002-04-30 2005-11-24 The Population Council, Inc. Carrageenan based antimicrobial compositions
US20080241271A1 (en) * 2006-11-08 2008-10-02 Roman Stephen B Foaming anti-adhesion composition

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Centers for Disease Control and Prevention, "Vaccine Effectiveness - How Well Does the Flu Vaccine Work?", two pages; page last updated 13 October 2011; can be accessed at http://www.cdc.gov/flu/about/qa/vaccineeffect.htm *
Food and Drug Administration, U.S. Department of Health and Human Services, "Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics", May 1999, total 56 pages *
Tsintsadze, Ted, Annals of Biomedical Research and Education, "Application of Antiviral Preparation "Super Lysine Plus" in a Complex of Treatment of Chronic Recurrent Herpetic Stomatitis", April/June 2004, vol. 4, issue 2, pp.92-93 *
Turner, Ronald, Merck Manual Professional, "Respiratory Viruses: Adenovirus Infection", total two pages; last review/revision October 2009; also can be accessed at http://www.merckmanuals.com/professional/print/infectious_diseases/respiratory_viruses/adenovirus_infection.html *
Turner, Ronald, Merck Manual Professionals, "Respiratory Viruses: Common Cold", two total pages; last review/revision October 2009; also can be accessed at http://www.merckmanuals.com/professional/print/infectious_diseases/respiratory_viruses/common_cold.html *
WordNet Search 3.0, "prevent", also can be accessed at http://wordnetweb.princeton.edu/perl/webwn?s=prevent&o2=&o0=1&o8=1&o1=1&o7=&o5=&o9=&o6=&o3=&o4=&h=; last viewed 10 March 2012 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10646438B2 (en) 2010-07-26 2020-05-12 Board Of Regents, The University Of Texas System Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
US11801218B2 (en) 2010-07-26 2023-10-31 Board Of Regents, The University Of Texas System Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
WO2013006795A2 (en) 2011-07-07 2013-01-10 Humanitas International Foundation Antiviral compositions and methods of their use
US20160296616A1 (en) * 2013-01-25 2016-10-13 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
US9974850B2 (en) * 2013-01-25 2018-05-22 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
CN114569549A (zh) * 2013-12-03 2022-06-03 格罗力马托斯国际有限公司 离子水性组合物
US10220055B2 (en) 2014-01-22 2019-03-05 Nicox S.A. Composition effective against viral conjunctivitis
US10279029B2 (en) 2015-03-25 2019-05-07 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
US10751409B2 (en) 2015-03-25 2020-08-25 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
US11801295B2 (en) 2015-03-25 2023-10-31 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
US10660914B2 (en) * 2015-07-14 2020-05-26 Marinomed Biotech Ag Stuffy nose deblocking composition having antiviral activity
US10434119B2 (en) * 2016-01-13 2019-10-08 Gargle Water, Inc. Pharyngeal or buccal cavity rinse and process of use thereof
US20170196783A1 (en) * 2016-01-13 2017-07-13 Jehangir Gowani Pharyngeal or buccal cavity rinse and process of use thereof
WO2019046426A1 (en) * 2017-08-30 2019-03-07 Applied Biological Laboratories, Inc. COMPOSITIONS AND METHODS FOR PROTECTING PATHOGENS AND IRRITANTS IN AIR SUSPENSION
WO2021168173A1 (en) * 2020-02-20 2021-08-26 Synkine Therapeutics, Inc. Methods and compositions for treating viral respiratory infections
WO2021202952A1 (en) * 2020-04-02 2021-10-07 Linhardt Robert John Compositions incorporating sulfated polysaccharides for inhibiting sars-cov-2
CN114264530A (zh) * 2021-12-30 2022-04-01 重庆市畜牧科学院 一种基于Avicel的病毒蚀斑测定方法及其应用

Also Published As

Publication number Publication date
ZA201000951B (en) 2011-04-28
DK2178533T3 (da) 2013-05-27
AP2010005170A0 (en) 2010-02-28
CA2696009A1 (en) 2009-03-05
AP2630A (en) 2013-03-28
MX2010001986A (es) 2010-03-11
BRPI0815748B8 (pt) 2021-05-25
CY1113949T1 (el) 2016-07-27
US10342820B2 (en) 2019-07-09
EA018138B1 (ru) 2013-05-30
US20120237572A1 (en) 2012-09-20
EA201070299A1 (ru) 2010-08-30
EP2178533B1 (en) 2013-03-27
KR20100045468A (ko) 2010-05-03
MY153900A (en) 2015-04-15
KR101571571B1 (ko) 2015-11-24
NZ583511A (en) 2012-02-24
UA102673C2 (ru) 2013-08-12
NO20100097L (no) 2010-03-24
AU2008291290A1 (en) 2009-03-05
PL2178533T3 (pl) 2013-08-30
SI2178533T1 (sl) 2013-07-31
PT2178533E (pt) 2013-06-03
BRPI0815748A2 (pt) 2015-02-18
EP2178533A1 (en) 2010-04-28
ES2406684T3 (es) 2013-06-07
IL203444A (en) 2015-05-31
HK1144558A1 (en) 2011-02-25
HRP20130402T1 (hr) 2013-06-30
CA2696009C (en) 2016-08-02
TN2010000086A1 (en) 2011-09-26
JP2011512319A (ja) 2011-04-21
JP5647518B2 (ja) 2014-12-24
CN101784272A (zh) 2010-07-21
WO2009027057A1 (en) 2009-03-05
BRPI0815748B1 (pt) 2019-04-24
MA31748B1 (fr) 2010-10-01
CN101784272B (zh) 2014-03-12

Similar Documents

Publication Publication Date Title
US10342820B2 (en) Antiviral composition comprising a sulfated polysaccharide
CA2671317C (en) Antiviral composition and method of use
US10376537B2 (en) Antiviral composition and method of use
EP3939597A1 (en) Antiviral pharmaceutical composition comprising a carrageenan component
EP1930015A1 (en) Use of carrageenan for treating rhinovirus infections
AU2008291290B2 (en) Antiviral composition comprising a sulfated polysaccharide
Couch Influenza: Advances in Knowledge of Impact and Approaches to Control

Legal Events

Date Code Title Description
AS Assignment

Owner name: MARINOMED BIOTECHNOLOGIE GMBH, AUSTRIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GRASSAUER, ANDREAS;PRIESCHL-GRASSAUER, EVA;REEL/FRAME:023988/0365

Effective date: 20100204

Owner name: MARINOMED BIOTECHNOLOGIE GMBH, AUSTRIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GRASSAUER, ANDREAS;PRIESCHL-GRASSAUER, EVA;REEL/FRAME:023988/0108

Effective date: 20100204

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION